StockWatch: Illumina Tumbles on Q4 Results, China Retaliation
Illumina (NASDAQ: ILMN) shares tumbled 16% this past week as investors reeled from a one-two punch of mixed fourth-quarter and full-year 2024 results, plus the prospect of losing all its revenue from China among...
Mapping Gas Adsorption on Platinum and Gold ‘Crown’ Structures Linked by Nanotunnels
Tokyo Metropolitan University researchers have made significant strides in understanding the behavior of gases interacting with metal cluster-containing crystalline solids. The study focuses on a unique solid compound, -H, identified as PtAu8-PMo12, demonstrating critical...
Revolutionary High-Frequency Enhanced Ultrafast Compressed Photography Technology Captures Microscopic Ultrathin Movies Instantly
High-frequency enhanced ultrafast compressed active photography (H-CAP) represents a significant breakthrough in the field of imaging technology, particularly for capturing transient phenomena that occur at extremely rapid time scales. This advancement merges the realms...
Insilico Medicine develops highly selective FGFR2/3 dual inhibitor for cancer treatment
Fibroblast growth factor receptors (FGFRs) are critical drivers of oncogenesis in various solid tumors, including urothelial carcinoma, hepatocellular carcinoma, ovarian cancer and lung adenocarcinoma. However, developing highly selective FGFR2/3 inhibitors and overcoming drug resistance...
Fossilized Bird Skull from the Dinosaur Era Sheds Light on Avian Evolution
A groundbreaking study published in the prestigious journal Nature details a remarkable discovery that sheds significant light on the evolutionary history of birds. The research focuses on the analysis of a nearly complete and...
Recoding E. coli Genome for Programmable Synthetic Proteins
A team of Yale synthetic biologists report that they were able to re-write the genetic code of E. coli—a novel genomically recoded organism (GRO) with one stop codon—using a cellular platform that they developed...
AI-based technology accelerates discovery of new tuberculosis drug candidates
Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and into the lungs, the pathogen that causes "TB" can lead to chronic cough,...
Advancing Biomaterial Development for Enhanced Cancer Treatment Solutions
Researchers at Virginia Tech’s Fralin Biomedical Research Institute are exploring innovative approaches in cancer therapy by modifying the physical characteristics of microscopic biomaterials. The promising work led by DaeYong Lee, an assistant professor at...
Multi-Omic Spatial Maps Use Retinal Thickness to Detect Systemic Disease
The condition of the eye’s retina, and in particular the measure of retinal thickness (influenced by factors such as the amount of vascularization, atrophy, ischemic damage, and the presence or absence of rod and...
Broken String Biosciences Launches INDUCE-seq Catalyst Program
Broken String Biosciences launched an early access program (EAP) through which select developers of gene edited therapeutics will be able to use Broken String’s INDUCE-seq® technology in their own labs for detecting and quantifying...
